Liposome-Mediated Macrophage Activities

Richard Kirsh, George Poste

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


This chapter discusses the relevant methodology for evaluating liposome behaviour in vivo with particular emphasis on the elevation of liposome-encapsulated biological response modifier (BRM) to augment macrophage-mediated host defences against neoplastic and infectious diseases. Liposome-encapsulated antifungal drugs might reasonably be expected to have limited success in treatment of infections with the more common opportunistic fungi, where the organisms grow extracellularly. However, selective delivery of antifungal agents to macrophages may still be therapeutically useful. Phagocytic uptake of fungi by macrophages that contain drug would be expected to enhance intracellular destruction of the phagocytosed organisms. In addition, macrophages that have phagocytosed liposomes, containing drug might act as a mobile slow-release depot. For example, macrophages that endocytosed liposomes containing antifungal drugs, while in the circulation may migrate to the site of infection and release drugs locally over a prolonged period.

Original languageEnglish (US)
Pages (from-to)147-157
Number of pages11
JournalMethods in Enzymology
Issue numberC
StatePublished - Jan 1987
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology


Dive into the research topics of 'Liposome-Mediated Macrophage Activities'. Together they form a unique fingerprint.

Cite this